Showing results (61-70 of 4,635) with videos related to
Sort By:
Pageof 464
Anti-Cancer Drugs|January 22, 1998
Sodium valproate inhibits in vivo growth of human neuroblastoma cellsJ Cinatl, J Cinatl, P H Driever, et al.Anti-Cancer Drugs|January 22, 1998
Targeted cytotoxic luteinizing hormone releasing hormone (LH-RH) anlalogs inhibit growth of estrogen independent MXT mouse mammary cancers in vivo by decreasing cell proliferation and inducing apoptosisK Szepeshazi, A V Schally, A Nagy, et al.Anti-Cancer Drugs|January 22, 1998
Induction of apoptosis and regression of spontaneous dog melanoma following in vivo application of synthetic cyclin-dependent kinase inhibitor olomoucineM Hajdúch, Z Kolár, R Novotný, et al.Anti-Cancer Drugs|March 24, 1998
Cisplatin-DNA adducts and protein-bound platinum in blood of testicular cancer patientsP Boffetta, A M Fichtinger-Schepman, E Weiderpass, et al.Anti-Cancer Drugs|March 24, 1998
A phase I/II trial of paclitaxel for non-Hodgkin's lymphoma followed by paclitaxel plus quinine in drug-resistant diseaseT P Miller, E M Chase, R Dorr, et al.Anti-Cancer Drugs|March 24, 1998
Synergistic interaction of selected marine animal anticancer drugs against human diffuse large cell lymphomaR M Mohammad, G R Pettit, V P Almatchy, et al.Anti-Cancer Drugs|March 10, 1998
Continuing the fight against advanced colorectal cancer: new and future treatment optionsH BleibergAnti-Cancer Drugs|March 10, 1998
Vorozole (Rivizor): an active and well tolerated new aromatase inhibitor for the treatment of advanced breast cancer patients with prior tamoxifen exposure. Investigational Drug Branch of the European Organization for Research and Treatment of Cancer (EORTC) Breast Cancer Cooperative GroupR Paridaens, J A Roy, M Nooij, et al.Anti-Cancer Drugs|March 10, 1998
Cytotoxicity and intracellular biotransformation of N-benzyladriamycin-14-valerate (AD 198) are modulated by changes in 14-O-acyl chain lengthL Lothstein, P J Rodrigues, T W Sweatman, et al.Anti-Cancer Drugs|March 10, 1998
Induction of apoptosis in human leukemic U937 cells by tetrandrineY L Lai, Y J Chen, T Y Wu, et al.Pageof 464